Free shipping on all orders over $ 500

Lifirafenib (BGB-283)

Cat. No. M10475

All AbMole products are for research use only, cannot be used for human consumption.

Lifirafenib (BGB-283) Structure
Synonym:

Beigene-283

Size Price Availability Quantity
1mg USD 40 In stock
5mg USD 90 In stock
10mg USD 150 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Lifirafenib (BGB-283) is a novel potent and selective RAF Kinase and EGFR inhibitor with IC50 values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant. In BRAFV600E colorectal cancer cell lines, BGB-283 effectively inhibits the reactivation of EGFR and EGFR-mediated cell proliferation. BGB-283 inhibits the EGF-induced EGFR autophosphorylation on Tyr1068 in A431 cells in a dose-dependent manner.

In vivo, BGB-283 treatment leads to dose-dependent tumor growth inhibition accompanied by partial and complete tumor regressions in both cell-line derived and primary human colorectal tumor xenografts bearing B-RAFV600E mutation.

Chemical Information
Molecular Weight 478.42
Formula C25H17F3N4O3
CAS Number 1446090-79-4
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Xi Yuan, et al. Mol Oncol. RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors

[2] Hiroshi Kotani, et al. Oncogene. Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers

[3] Zhiyu Tang, et al. Mol Cancer Ther. BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers

Related Raf Products
GDC-0879

GDC-0879 is a potent and selective B-Raf kinase inhibitor with an EC50 of 0.75 µM.

Vemurafenib (PLX4032)

Vemurafenib (PLX4032) is a first-in-class, potent, selective inhibitor of B-Raf that inhibits RAFV600E and C-RAF-1 activity with IC50s of 31 nM and 48 nM, respectively.In addition, Vemurafenib induces autophagy.

PLX-4720

PLX-4720 is a selective BRAFV600E inhibitor with the IC50 values of 160 nM and 130 nM for B-Raf and BRK respectively.

SB590885

SB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively.

ZM 336372

ZM 336372 is a potent, selective ATP-competitive inhibitor of c-Raf in vitro (IC50 = 70 nM for inhibition of human c-Raf).

  Catalog
Abmole Inhibitor Catalog




Keywords: Lifirafenib (BGB-283), Beigene-283 supplier, Raf, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.